Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and ...

The open benchmark competition will evaluate the ability of AI-powered virtual cell models to generalize to new cell contexts ...

Vetter has invested approximately $285 million in the new Des Plaines clinical manufacturing site, which is expected to open ...

A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle ...

When the macrophages’ ability to consume dying cancer cells or Upd3 production was decreased, tumor growth was significantly ...

Iya Khalil, PhD, discusses Merck & Co.’s approach to artificial intelligence (AI), and success in applying the technology, ...

In this GEN panel discussion, three experts in cell and gene therapy development will share lessons and strategies learned ...

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

The company has integrated the AI model into its internal discovery pipeline and aims to use it in collaborative drug ...

The AI unicorn's Perturb-seq atlas is publicly available and detects dose-dependent genetic effects to enhance predictive ...

The SAIR database is designed to help scientists train AI models to better predict protein-ligand binding affinities for drug ...

EM, researchers elucidated the structure of key receptors integral to fast excitatory synaptic transmission in the rat ...